High-dose vitamins and minerals offer no benefit for recurrent 'cardiac events'
Supplementation with vitamins and minerals does not help to reduce recurrences of cardiac events in people who have suffered a heart attack, says research.
Archives for March 13, 2013
Danone tops nutrition commitment index despite infant formula marketing ‘concerns’
Danone has topped the Access to Nutrition Index (ATNI) for its efforts to address issues such as obesity and malnutrition - despite “significant concerns” about the company’s lack of compliance with infant formula marketing codes.
Deerland Enzymes launches new products to tackle food intolerances
Leading enzyme-based dietary supplement formulator has released two new products targeting gluten and lactose intolerance, conditions that affect over one third of the US population.
Legal troubles over, Biova flexes muscles in joint health markets
Eggshell membrane ingredient supplier Biova LLC is starting to flex its muscles in the joint health markets now that a lengthy and draining patent litigation case is settled.
Bitter melon may offer 'exciting' cancer promise
Bitter melon juice may prevent the development of pancreatic cancer by cutting off the fuel supply to cancerous cells, according to new data.
Pfizer multivitamin TV ads mislead consumers about healthy diets, says UK watchdog
TV advert claims for Pfizer owned Centrum multivitamins that used EU-approved health claims were still misleading because they did not make clear that a balanced diet could be achieved without supplements, the UK advertising watchdog has found.
Norway ranks four amino acids as “high risk”
The Norwegian Scientific Committee for Food Safety (VKM) has classed four amino acids – histidine, methionine, S-adenosylmethionine (SAM) and tryptophan – as high-risk and linked to problems like nausea, dizziness and increased blood pressure.
Chromadex cements position in NR market with third IP acquisition
Chromadex has announced a licensing deal with Washington University in St. Louis for the worldwide exclusive patent rights related to the recently discovered vitamin nicotinamide riboside (NR). It is Chromadex’s third IP acquisition related to the molecule.
Medicus’ Wellness App to help consumers with supplement compliance
Medicus Research is rolling out its software engine from clinical trials as Wellness Apps for dietary supplement brands intended to help consumers track their own compliance and send reminders to re-purchase.